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Abstract 
Objective: Palliative and hospice care have been shown to benefit people with dementia and their 
families. However, for patients with dementia who are nearing the end of life, hospice referral 
can be challenging because of the difficulty in predicting prognosis. The objective of this 
retrospective, exploratory study is two-fold: (1) to describe trajectories by analyzing trends in 
Palliative Performance Scale (PPS) scores for patients admitted to hospice with a neurocognitive 
disorder from time of enrollment to time of disenrollment and (2) to determine the relationship 
between PPS and length of stay (LOS) in hospice care.  
Methods: The setting for the study is a geriatrics clinic in west central Ohio. Data collection 
utilized the Athena™ EMR to identify patients with a neurocognitive disorder who were enrolled 
in a home-based hospice program between January 1, 2015 and December 31, 2018. PPS scores 
for 55 patients were recorded from periodic hospice documents submitted to the attending 
physicians in the geriatrics clinic and from progress notes entered by the geriatricians, as they co-
managed the patients alongside hospice. 
Nasr 2 
 
Results: Fifty-five patients received care across five hospices during the study period. Of those 
included, 22 had a primary diagnosis of Alzheimer's dementia, and 33 had vascular dementia. 
The median length of stay in hospice care was 93 days, with death being the reason for discharge 
in all but one patient. Median length of stay decreased incrementally with each decrease in initial 
PPS score. With regard to PPS changes over time, there was wide variability in individual 
trajectories, which demonstrates the highly variable and unpredictable nature of dementia. 
Almost three quarters of the study population died prior to the 6-month mark in hospice care, 
suggesting that patients with dementia may be receiving hospice care later than they qualify. 
Key Words: palliative; performance; scale; hospice; dementia; Alzheimer; prognosis 
Introduction/Literature Review 
Dementia 
Dementia is a diagnosis that encompasses numerous etiologies and shows variable 
expression among patients. It is becoming more prevalent every year. In 2017, the World Health 
Organization estimated that about 50 million people worldwide have some form of dementia, 
with approximately 10 million new cases each year.1 It is a progressive and incurable disease. 
Despite the increasing number of cases and severity of symptoms, patients with advanced forms 
of dementia are underrepresented in palliative care compared to those with other diagnoses.2 
There are several reasons why this may be the case, including ambiguities in eligibility criteria 
and difficulties in classifying disease stages. 
When it comes to terminal illnesses like end-stage dementia, palliative care is crucial for 
maintaining comfort and quality of life throughout the dying process. Surveys completed by 
relatives of deceased patients with dementia reported increased quality of care, fewer unmet 
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needs, and greater emotional support while in hospice care compared to non-hospice care.3 In 
2018, Harrop et al. created a program to provide social workers and peer groups to patients and 
families receiving palliative care. Outcomes included self-reported improvements for patients 
and caregivers alike, including fewer cases of isolation and an improved sense of feeling “at 
home” among patients.4 Despite the apparent benefits of hospice, gaining access to palliative care 
for patients with dementia can be complex, especially in the early stages of disease. 
Hospice Eligibility and Prognosis 
The majority of deaths in older patients with dementia occur in the setting of a nursing 
facility.2 However, it has been shown that patients with advanced dementia in nursing facilities 
who receive hospice care have lower risks of dying in the hospital.5 The spectrum of patients 
served by hospice is evolving, and every disease has a unique progression. This variability makes 
it difficult to establish specific criteria for hospice enrollment. Hospice eligibility has been a 
dynamic and sometimes controversial issue. As such, there have been studies that analyze 
hospice eligibility requirements and their role in patient care. 
Current hospice eligibility for people with dementia is based on etiology and FAST 
(functional assessment screening tool) scores. Shown in Table 1, FAST is a scale from 1 to 7 
derived from a standardized instrument, with one being “normal” aging, and seven being 
advanced dementia. Most guidelines today require that a patient is FAST stage 7a or greater, 
which implies severe dementia. These patients are mainly non-ambulatory or have limited ability 
to speak. Recent studies have shown that this assessment alone is not sufficient to indicate 





1 - Normal Aging No subjective or objective difficulty 
2 - Possible MCI* Subjective functional deficit 
3 - MCI Objective functional deficit, interferes with complex tasks 
4 - Mild Dementia Deficits in IADLs 
5 - Moderate Dementia Needs help selecting proper attire 
6a - Moderately Severe 
Dementia 
Needs help dressing 
6b - Moderately Severe 
Dementia 
Needs help bathing 
6c - Moderately Severe 
Dementia 
Needs help toileting 
6d - Moderately Severe 
Dementia 
Urinary incontinence 
6e - Moderately Severe 
Dementia 
Fecal incontinence 
7a - Severe Dementia Ability to speak limited (1 to 5 words a day) 
7b - Severe Dementia All intelligible vocabulary lost 
7c - Severe Dementia Unable to ambulate without assistance 
7d - Severe Dementia Unable to sit up without assistance 
7e - Severe Dementia Unable to smile 
7f - Severe Dementia Unable to hold head up 
Table 1: FAST Scale 
*MCI = Mild Cognitive Impairment 
 
Prognosis is determined by numerous factors, including marital status, dementia-driven 
symptoms such as anorexia, and comorbidities like hypertension, stroke, and diabetes mellitus.7 
The Advanced Dementia Prognostic Tool (ADEPT) has been an alternative way to estimate 
prognosis. In 2010, Mitchell et al. aimed to determine reliability of this tool in the nursing home 
setting. The conclusion was that ADEPT was modestly better at predicting a 6-month survival 
time than hospice eligibility guidelines.8 The results of this study, combined with results of 
studies on FAST, show that current eligibility guidelines are lacking when it comes to prognosis 
for patients with dementia. In terms of LOS in hospice care, a longitudinal study in 2017 found 
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that the mean length of stay in hospice for those without a primary diagnosis of dementia versus 
those whose primary diagnosis was dementia was 74 days and 112 days, respectively.9 
Palliative Performance Scale 
The palliative performance scale (PPS) was created in 1994 by Anderson, et al. as a 
modification of the Karnofsky Performance Scale. It was established due to an increasing need to 
assess functional capacity and decline in patients receiving palliative care.10 The scale works on 
a percentage basis and declines by increments of ten. One hundred percent represents a person 
whose medical condition does not affect overall functioning, while zero represents death. Table 2 
shows PPS descriptors, as adapted from The Victoria Hospice Society. Today, the scale 
functions on two levels. Not only does it act as a reference for the assessment of a patient’s status 
and prognosis, but it is also used to assess hospice eligibility across a spectrum of relevant 
diseases. 
PPS Ambulation Activity & 
Evidence of 
Disease 
Self-Care Intake Level of 
Consciousness 
100% Full Normal activity & 
work  
No evidence of 
disease 
 
Full Normal Full 
90% Full Normal activity & 
work  
Some evidence of 
disease 
 
Full Normal Full 
80% Full Normal activity 
with effort  
Some evidence of 
disease 
 
Full Normal or 
Reduced 
Full 
70% Reduced Unable to do 
normal work 
Significant disease 




































Full or Drowsy 
+/- Confusion 
30% Totally bed 
bound 




Total Care Normal or 
Reduced 
Full or Drowsy 
+/- Confusion 
20% Totally bed 
bound 




Total Care Minimal to 
sips 
Full or Drowsy 
+/- Confusion 
10% Totally bed 
bound 




Total Care Mouth care 
only 
Drowsy or Coma 
+/- Confusion 
0% Death - - - - 
Table 2: PPS descriptors 
Due to the emergence of literature, the PPS has become an addition to assessments used 
for hospice eligibility. Myers et al. concluded that specific PPS stages in patients with advanced 
cancer can be used for conducting key care discussions among patients and clinicians.11 These 
discussions help direct medical decisions to provide the highest quality care. Palliative 
performance scale, unlike ADEPT, is not specifically for dementia; it can be used to assess 
patient functioning at the end of life due to any cause. In a study by Jansen et al., initial PPS 
score was compared between those with dementia and those with other diagnoses. It was found 
that although most patients in both groups died within three months, PPS score at time of 
enrollment for patients with dementia varied by as much as 60%.12 In a separate study, Lo et al. 
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concluded that patients with a diagnosis of advanced dementia had lower PPS scores on average 
than patients with other diagnoses. Despite this, there appeared to be no difference in LOS 
between the two groups.13 Studies like these endorse the idea that prognosis for people with 
dementia is particularly difficult to predict when compared to other diseases. 
Although the PPS has been increasingly studied in recent years, there are gaps in the 
literature regarding its utilization in clinical practice. For patients with dementia, there is 
literature regarding PPS status at time of hospice admission, but little exists for how these scores 
change throughout the length of care. By analyzing PPS status throughout a patient’s entire time 
with hospice, trends may become apparent in functional decline. In this way, the PPS may be 
used as an additional tool for prognosis prediction in complex disease processes like dementia to 
ensure that patients are getting quality end-of-life care in a timely manner. 
Conclusion 
The goal of this study is to track PPS scores in patients with dementia from time of hospice 
enrollment until the end of care. Final PPS scores will also be compared to specific outcomes of 
care and length of stay with hospice. By analyzing trends in functional decline, insight may be 
gained into prognosis for dementia. As such, the utilization of PPS scores may alter important 
care decisions, including appropriate timing for hospice enrollment. 
Specific Aims: 
1. Determine PPS at time of hospice enrollment for Wright State Physicians Geriatrics clinic 
patients with major neurocognitive disorder. 
2. Describe PPS trajectories from enrollment to time of discharge from hospice because of death, 
extended prognosis, or family decision to dis-enroll. 
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3. Determine the relationship between PPS and length of stay (LOS) in hospice care. 
Methods 
Context/Protocol 
The setting for this study is a geriatrics clinic in a faculty practice affiliated with a 
community-based medical school. The 55 subjects included in the study are patients from the 
Wright State Physicians Geriatrics clinic whose information is extracted from Athena EMR. 
Patients with a diagnosis of dementia who were enrolled in a home-based hospice program 
between January 1, 2015 and December 31, 2018 were included. The diagnosis of dementia 
includes Alzheimer’s disease, frontotemporal lobar degeneration, Lewy body disease, and 
vascular dementia. Patients without a primary diagnosis of any of the above were excluded from 
the data group. 
Data Collection 
Following IRB approval, data was gathered on the number of patients from the geriatrics 
practice admitted to hospice, their PPS at admission, and discharge information. PPS was 
determined by chart review from initial hospice evaluation and intermittent and final hospice 
reports. These assessments of patient function are based on information from patients 
themselves, a knowledgeable informant, and a healthcare professional skilled in the diagnosis of 
dementia. Additionally, formal neuropsychological testing or the MOCA (Montreal Cognitive 
Assessment) had provided objective support for a major neurocognitive disorder. The observed 
cognitive deficits have been determined to interfere initially with performance in all IADLs, 
followed by increasing dependence in ADLs. Finally, the impact of comorbidities on overall 
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functional status was taken into account. While compiling this data, there was no direct 
interaction with patients, and confidentiality was maintained by use of a number system. 
Data Analysis 
 Univariate procedures included means, medians, and counts. PPS scores were compiled 
for each patient over time, and each individual’s trajectory was plotted on one graph. All patients 
were compiled together in one figure to visually display trends. Group trends were displayed 
using LOESS smoothing to account for the visually nonlinear form of the trajectories. A test for 
trend with PPS scores and LOS was conducted using a general linear model with PPS score 
group entered as a continuous variable and LOS as the outcome variable (normality of the data 
distribution was assumed for this test). Data analysis was completed with Dr. Peterson, a 
geriatric researcher, using SAS version 9.4. 
Results 
 The study population of 55 subjects included 35 women and 20 men, with an average age 
of 85 years old. Twenty-two had a primary diagnosis of Alzheimer's dementia, while 33 had 
vascular dementia. The median length of enrollment in hospice across all patients was 93 days, 
or about three months. For the population with Alzheimer’s and vascular dementia, average LOS 
was 114 and 120, respectively. In terms of comorbidities, 35 patients had concurrent 
hypertension, 15 had a history of stroke, and 24 had coronary artery disease. Diabetes was 
present in 8 patients, and 11 had atrial fibrillation. Ten patients had concurrent Parkinson-like 
symptoms, which may be related to side effects of antipsychotic medications or to Parkinson’s 
disease. Regarding outcomes, one patient was discharged due to extended prognosis, while all 
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others were disenrolled due to death. Two patients included in data analysis are still currently 
enrolled in hospice care, and do not have discharge information to include. 
For PPS, admitting scores ranged from 40 to 10, with an average of 22. At discharge, 
values ranged from 30 to 0, with an average of 9.6. Table 3 shows the initial PPS scores and their 
corresponding mean and median LOS in hospice care. There was a significant linear trend (P < 
0.0001) associated with lower initial PPS and shorter LOS. For the 10 patients with Parkinson’s 
disease, average LOS was below the mean at 83 days. 






Initial PPS n Mean/median LOS 
10 20 31.65/18.5 
20 11 130.6/106 
30 17 164.7/148 
40 6 226.7/251 
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Figure 1 illustrates PPS trajectories for each individual patient. The bolded line gives a 
trajectory for the group as a whole. From this figure, it is evident that there is an initial drop in 
PPS within the first month of care, while values level off thereafter. 
 Figure 1: PPS trajectories 
Table 4 provides details about the 6 patients (3 men and 3 women) who had a PPS of 40 at 
the time of enrollment. Patient A had a length of stay of 73 days while the length of stay for each 
of the remaining 5 patients was over 200 days. Caregiver stress was a prominent feature among 5 
of the 6 patients with a PPS of 40 at the time of enrollment, with patient sleep disturbance being  

























Table 4: Patient characteristics with admitting PPS of 40 
Discussion 
This study takes an exploratory approach through the journey of hospice care for patients 
with dementia. Numerous studies demonstrate that hospice care improves overall outcomes in 
this patient population.3,4 However, the issue of hospice eligibility criteria has made it difficult 
for patients to enroll. The Palliative Performance Scale is an objective tool that used to assess 
patient functionality at the end of life and may be useful in assessments for hospice eligibility. 
The first aim of this study was to determine PPS scores at the time of hospice enrollment. As 
has been shown in previous studies, PPS for those with dementia showed wide variability at time 
of enrollment.12 This supports the prior notion that dementia is a highly variable disease that can 
Patient Age Gender Diagnosis Comment 
A 91 M Vascular Sleep disturbance due to OSA and inability to use 
CPAP; CHF; repetitive vocalizations; caregiver stress 
(younger spouse) 
B 90 F Vascular Recurrent episodes of pancreatitis; CHF; intermittent 
dysphagia; slowly decreasing albumin level; sleep 
disturbance; caregiver stress (daughter) 
C 74 F AD Slow weight loss; frequent falls; frightening 
delusions/hallucinations; sleep disturbance (no 
caregiver stress as spouse, 2 daughters, and 1 
granddaughter shared caregiving) 
D 96 F Vascular PVD with recurrent arterial ulcers; painful peripheral 
neuropathy; sleep disturbance; caregiver stress (3 
daughters with different goals and expectations) 
E 91  M Vascular Recurrent vertebral fractures; frequent falls; pacing; 
resistive to care; distressing delusions; caregiver stress 
(daughter) 
F 62 M AD Aggressive behavior; delusions; hallucinations; 




be difficult to predict. Additionally, the maximum initial PPS was 40, indicating that all patients 
were mainly bedridden, and required almost total assistance in providing self-care at the time of 
enrollment. 
In attempts to correlate PPS with prognosis, it is also important to discuss length of hospice 
care. The median LOS for the 53 patients in the study who disenrolled from care was 85 days, or 
just under three months. This is similar to previous studies that have explored LOS in hospice for 
patients with dementia.9 However, the LOS values had a wide range, from 1 day to just over a 
year at 381 days. Once again, this highlights the variability in prognosis for patients with 
dementia. To make a hospice referral, a physician must affirm that the patient has a life 
expectancy of 6 months or less to meet criteria for enrollment. Our data shows that almost 75% 
of the study population died prior to the 6-month mark.    
In describing the trends of PPS as a population overall, it is evident that PPS remained 
generally constant after an initial 5-point drop in the first 30 days of enrollment. Finally, in 
comparing comorbidities and their effects on outcomes, it is interesting to note that for patients 
with concurrent Parkinsonism, the average LOS in hospice care was over one month shorter than 
average LOS for all other patients. 
Conclusion 
 Findings in this study show a significant linear correlation between initial PPS and LOS 
in hospice for patients with dementia. Small sample size is the main limitation. The final sample 
size was 55, with two of those patients still currently enrolled in hospice care. Additionally, 
demographics were not a main focus of the study, including comparisons in outcomes between 
genders and various ethnic groups. It is important to consider that only two etiologies of 
Nasr 14 
 
dementia were studied here. There are several other causes of dementia, and that information 
would be important to explore in future studies. Finally, the logistics of assessing a patient’s PPS 
score may be another limitation. Although PPS is an objective measure of functional decline, it is 
important to note that two different providers performing these assessments may not give 
identical scores to the same patient. Furthermore, PPS assessments are not always conducted at 
regular intervals, which can make it difficult to assess the data accurately.    
Future directions for research of this type may include closer investigations into etiology of 
dementia and patient comorbidities to assess their specific effects on prognosis. It may also be 
valuable to conduct a prospective study to trend PPS over time at regularly spaced intervals for 
cleaner analysis. There is still much to be learned when it comes to prognosis for patients with 
dementia. As hospice eligibility continues to evolve, finding ways to provide the best possible 













1. World Health Organization. Dementia fact sheet. http://www.who.int/news-room/fact-
sheets/detail/dementia. Accessed July 27, 2018. 
2. Mitchell SL, Teno JM, Miller SC, Mor V. A national study of the location of death for older 
persons with dementia. JAGS. 2005;53(2):299-305. doi: 10.1111/j.1532-5415.2005.53118.x. 
3. Teno JM, Gozalo PL, Lee IC, Kuo S, Spence C, Connor SR, Casarett DJ. Does hospice 
improve quality of care for persons dying from dementia? JAGS. 2011;59(8):1531-1536. doi: 
10.1111/j.1532-5415.2011.03505.x. 
4. Harrop E, Nelson A, Rees H, Harris D, Noble S. The challenge pathway: A mixed methods 
evaluation of an innovative care model for the palliative and end-of-life care of people with 
dementia (Innovative practice). Dementia. 2018;17(2):252-257. doi: 
10.1177/1471301217729532. 
5. Miller SC, Lima JC, Looze J, Mitchell SL. Dying in U.S. nursing homes with advanced 
dementia: How does health care use differ for residents with, versus without, end-of-life 
Medicare skilled nursing facility? J Pall Med. 2012;15(1):43-50. doi: 10.1089/jpm.2011.0210. 
6. Brown MA, Sampson EL, Jones L, Barron AM. Prognostic indicators of 6-month mortality in 
elderly people with advanced dementia: A systematic review. Palliative Med. 2012;27(5):389-
400. doi: 10.1177/0269216312465649. 
7. Schonwetter RS, Han B, Small BJ, Martin B, Tope K, Haley WE. Predictors of 6-month 
survival among patients with dementia: An evaluation of hospice Medicare guidelines. J Hospice 
and Palliative Care. 2003;20(2):105-113. doi: 10.1177/104990910302000208. 
Nasr 16 
 
8.  Mitchell SL, Miller SC, Teno JM, Kiely DK, Davis RB, Shaffer, ML. Prediction of 6-month 
survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility 
guidelines. JAMA. 2010;304(17):1929-1935. doi: 10.1001/jama.2010.1572. 
9. DeVleminck A, Morrison RS, Meier DE, Aldridge MD. Hospice care for patients with 
dementia in the United States: A longitudinal cohort study. J Am Med Dir. 2017;19(7):633-638. 
doi: 10.1016/j.jamda.2017.10.003.  
10. Anderson F, Downing M, Hill J. Palliative performance scale (PPS): A new tool. J Palliative 
Care. 1996;12(1):5-11. 
11. Myers J, Kim A, Flanagan J, Selby D. Palliative performance scale and survival among 
outpatients with advanced cancer. Support Care Cancer. 2015;23:913-918. doi: 10.1007/s00520-
014-2440-8. 
12. Jansen WJ, Buma S, Gootjes J, Zuurmond W, Perez R, Loer SA. The palliative performance 
scale applied in high-care residential hospice: A retrospective study. J Palliative Med. 
2015;18(1):67-70. doi: 10.1089/jpm.2013.0645. 
13. Lo AT, Karuza J, Berall A, Perri GA. Prevalence of dementia in a geriatric palliative care 
unit. Am J Hospice & Palliative Med. 2017;35(5):799-803. doi: 10.1177/1049909117737300. 
 
